Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Ranger Energy (RNGR) Lags Q4 Earnings and Revenue Estimates
Ranger Energy (RNGR) Lags Q4 Earnings and Revenue Estimates

Ranger Energy (RNGR) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.25 per share a year ago. These

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates
Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates

Kura Oncology (KURA) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to a loss of $0.22 per share a year ago. These figures

4 Value Stocks to Buy as Middle East Tensions Keep Markets on Edge
4 Value Stocks to Buy as Middle East Tensions Keep Markets on Edge

The U.S. stock market is walking a tightrope as investors weigh geopolitical volatility against resilient domestic data. After a bruising few days sparked by Middle East tensions, Wall Street

Blackbaud Expands AI Innovation to Boost Social Impact Outcomes
Blackbaud Expands AI Innovation to Boost Social Impact Outcomes

Blackbaud, Inc. BLKB recently highlighted a series of customer outcomes that demonstrate the tangible benefits of its innovative and intuitive platforms. These results underscore the strength of

Should You Buy Barrick Mining Stock After a 61% Rally in 6 Months?
Should You Buy Barrick Mining Stock After a 61% Rally in 6 Months?

Barrick Mining Corporation’s B shares have rallied 61.3% in the past six months, buoyed by the record-setting upswing in gold prices amid heightened geopolitical tensions, economic and

FCX's Unit Cash Costs Surge in Q4: Is It Set to Climb Further in Q1?
FCX's Unit Cash Costs Surge in Q4: Is It Set to Climb Further in Q1?

Freeport-McMoRan Inc. FCX saw a sharp increase in its average unit net cash cost per pound of copper in the fourth quarter of 2025 to $2.22 from $1.40 in the prior quarter, marking a roughly 59%

AREC's ReElement Expands Advanced Rare Earth Laboratory Capacity
AREC's ReElement Expands Advanced Rare Earth Laboratory Capacity

American Resources Corporation AREC, through its portfolio company, ReElement Technologies Corporation, has expanded and commissioned advanced laboratory capabilities to further strengthen its rare

Chaos & Crude: 3 Energy Stocks Built to Thrive in This Market
Chaos & Crude: 3 Energy Stocks Built to Thrive in This Market

The daily ticker tape for the energy market is enough to give any investor a case of whiplash. One moment, oil futures are surging on fears of a widening conflict in the Middle East; the next

DOV Boosts CO2 Refrigeration Leadership With Next Generation Flex Mini
DOV Boosts CO2 Refrigeration Leadership With Next Generation Flex Mini

Dover Corporation’s DOV subsidiary Hillphoenix has expanded its CO2 refrigeration portfolio with the launch of the Next Generation Flex Mini, a compact, high-efficiency transcritical CO2 system

Bilibili (BILI) Surpasses Q4 Earnings and Revenue Estimates
Bilibili (BILI) Surpasses Q4 Earnings and Revenue Estimates

Bilibili (BILI) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.15 per share a year ago. These figures

Canadian Natural Resources (CNQ) Tops Q4 Earnings and Revenue Estimates
Canadian Natural Resources (CNQ) Tops Q4 Earnings and Revenue Estimates

Canadian Natural Resources (CNQ) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.66 per share a year

Merck KGaA (MKKGY) Lags Q4 Earnings Estimates
Merck KGaA (MKKGY) Lags Q4 Earnings Estimates

Merck KGaA (MKKGY) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.54 per share a year ago. These

Is Eventide Gilead Fund N (ETGLX) a Strong Mutual Fund Pick Right Now?
Is Eventide Gilead Fund N (ETGLX) a Strong Mutual Fund Pick Right Now?

Any investors hoping to find a Mid Cap Growth fund could think about starting with Eventide Gilead Fund N (ETGLX). ETGLX holds a Zacks Mutual Fund Rank of 3 (Hold), which is based on various

Is Fidelity Emerging Asia Fund (FSEAX) a Strong Mutual Fund Pick Right Now?
Is Fidelity Emerging Asia Fund (FSEAX) a Strong Mutual Fund Pick Right Now?

On the lookout for a Pacific Rim - Equity fund? Starting with Fidelity Emerging Asia Fund (FSEAX) is one possibility. FSEAX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on various

Is T. Rowe Price Tax-Efficient Equity (PREFX) a Strong Mutual Fund Pick Right Now?
Is T. Rowe Price Tax-Efficient Equity (PREFX) a Strong Mutual Fund Pick Right Now?

If you have been looking for Large Cap Growth funds, a place to start could be T. Rowe Price Tax-Efficient Equity (PREFX). PREFX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on

Is Columbia Seligman Technology & Information A (SLMCX) a Strong Mutual Fund Pick Right Now?
Is Columbia Seligman Technology & Information A (SLMCX) a Strong Mutual Fund Pick Right Now?

Sector - Tech fund seekers should consider taking a look at Columbia Seligman Technology & Information A (SLMCX). SLMCX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various

Is Schwab Fundamental International Small Company Index (SFILX) a Strong Mutual Fund Pick Right Now?
Is Schwab Fundamental International Small Company Index (SFILX) a Strong Mutual Fund Pick Right Now?

If you're looking for a Non US - Equity fund category, then a possible option is Schwab Fundamental International Small Company Index (SFILX). SFILX has no Zacks Mutual Fund Rank, but we have been

Telecom ETF (XTL) Touches New 52-Week High
Telecom ETF (XTL) Touches New 52-Week High

For investors seeking momentum, the State Street SPDR S&P Telecom ETF XTL is probably on the radar now. The fund just hit a 52-week high and is up 126.8% from its 52-week low price of $85.16 per

Is Xtrackers Net Zero Pathway Paris Aligned US Equity ETF (USNZ) a Strong ETF Right Now?
Is Xtrackers Net Zero Pathway Paris Aligned US Equity ETF (USNZ) a Strong ETF Right Now?

Designed to provide broad exposure to the Style Box - All Cap Blend category of the market, the Xtrackers Net Zero Pathway Paris Aligned US Equity ETF (USNZ) is a smart beta exchange traded fund

Is Invesco DB US Dollar Index Bullish ETF (UUP) a Strong ETF Right Now?
Is Invesco DB US Dollar Index Bullish ETF (UUP) a Strong ETF Right Now?

Launched on 02/20/2007, the Invesco DB US Dollar Index Bullish ETF (UUP) is a smart beta exchange traded fund offering broad exposure to the Currency ETFs category of the market.

What Are Smart

Is Hartford Multifactor Developed Markets (ex-US) ETF (RODM) a Strong ETF Right Now?
Is Hartford Multifactor Developed Markets (ex-US) ETF (RODM) a Strong ETF Right Now?

The Hartford Multifactor Developed Markets (ex-US) ETF (RODM) was launched on 02/25/2015, and is a smart beta exchange traded fund designed to offer broad exposure to the Foreign Large Value ETF

Is iShares MSCI USA Quality GARP ETF (GARP) a Strong ETF Right Now?
Is iShares MSCI USA Quality GARP ETF (GARP) a Strong ETF Right Now?

Launched on 01/14/2020, the iShares MSCI USA Quality GARP ETF (GARP) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Growth category of the market.

What Are

Is First Trust NASDAQ Transportation ETF (FTXR) a Strong ETF Right Now?
Is First Trust NASDAQ Transportation ETF (FTXR) a Strong ETF Right Now?

Designed to provide broad exposure to the Industrials ETFs category of the market, the First Trust NASDAQ Transportation ETF (FTXR) is a smart beta exchange traded fund launched on 09/20/2016.

What

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)
ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

Acadia Pharmaceuticals ACAD announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has formally adopted a negative opinion recommending

Best Value Stock to Buy for March 5th
Best Value Stock to Buy for March 5th

Here is a stock with buy rank and strong value characteristics for investors to consider today, March 5th:  

PACS Group, Inc. PACS: This company, which invests in post-acute healthcare facilities